← CorMedix Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $224k $329k $430k $283k $239k $191k $65k $2.7m $43.5m $311.7m
Cost of Goods and Services Sold ($367k) $115k $397k $206k $205k $149k $4k $2.0m $3.2m $22.1m
Gross Profit (derived) ($143k) $214k $33k ($90k) $34k $42k $62k $732k $40.3m $275.7m
Operating Expenses $24.6m $33.1m $26.9m $20.9m $27.3m $29.5m $30.7m $49.0m $62.6m $125.6m
Operating Income (Loss) ($24.8m) ($32.9m) ($26.9m) ($21.0m) ($27.2m) ($29.4m) ($30.6m) ($49.0m) ($22.4m) $150.1m
Additional Financial Items
Amortization of Intangible Assets — — — — — — — — $156k $13.9m
Fair Value, Option, Changes in Fair Value, Gain (Loss) $0 ($177k) $0 — — — — — — —
Foreign Currency Transaction Gain (Loss), before Tax ($8k) ($14k) ($179) ($21k) ($59k) ($21k) $37k ($29k) ($31k) ($52k)
Gain (Loss) on Investments $11k $13k $0 $268 — — — — — —
Income (Loss) Attributable to Parent, before Tax — — — — — — — — — $150.0m
Income (Loss) from Continuing Operations before Income Taxes, Domestic $24.8m $32.9m $26.9m $21.0m $27.2m $29.4m $30.6m ($45.9m) ($19.1m) $150.0m
Interest Income, Other — — — — — $14k $326k $2.7m — —
Operating Lease, Lease Income — — — $4k — — — — — —
Preferred Stock Dividends and Other Adjustments $0 — — — — — — — — —
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $24.8m $32.9m $26.9m ($21.5m) ($27.2m) ($29.5m) ($30.3m) — ($19.3m) $150.0m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent — — — — — — — — — $1.7m
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $24.8m $32.9m $26.9m $21.0m $27.2m $29.4m $30.6m ($46.3m) $22.4m $150.1m
Net Income (Loss) Attributable to Parent ($24.6m) ($33.0m) ($26.8m) ($16.4m) ($22.0m) ($28.2m) ($29.7m) ($46.3m) ($17.9m) $163.1m
Net Income (Loss) Available to Common Stockholders, Basic ($24.6m) ($33.0m) ($26.8m) ($43.5m) ($22.0m) ($28.2m) ($29.7m) ($46.3m) ($17.9m) $163.1m
Net Income (Loss) Attributable to Noncontrolling Interest — — — — — $28.2m — — — —
Earnings Per Share, Basic — — — — — ($0.75) ($0.74) ($0.91) ($0.30) $2.25
Earnings Per Share, Diluted ($0.65) ($0.60) ($1.51) ($1.80) ($0.77) ($0.75) ($0.74) ($0.91) ($0.30) $2.04
Weighted Average Number of Shares Outstanding, Basic — — — — — 37.7m 40.3m 50.9m 58.9m 72k
Weighted Average Number of Shares Outstanding, Diluted — — — — — — 40.3m 50.9m 58.9m 80k
Research and Development Expense $15.7m $24.5m $18.8m $11.1m $13.4m $13.1m $10.7m $13.2m $3.9m $19.3m
General and Administrative Expense $8.9m $8.7m $8.1m — — — — — $30.0m $68.2m
Selling, General and Administrative Expense — — — $9.9m $13.9m $16.3m $20.0m $35.8m — —
Other Nonoperating Income (Expense) — — $35k — $24k ($23k) $337k $2.6m — —
Interest Expense (non-operating) — — — — — — — — $36k $2.8m
Current Income Tax Expense (Benefit) — — — $5.1m $5.2m $1.3m $586k — $1.4m $12.8m
Interest Expense $1k $6k $2k $787k $33k $16k $27k $34k $36k $2.8m
Operating Lease, Expense — — — $6k $66k $209k $208k $207k $204k —
Other Expenses ($117k) $86k — $2k — — — — — —
Other General Expense — — — — $3.3m — — — — —
Selling and Marketing Expense — — — — — — — — $28.7m $38.1m
Income Tax Expense (Benefit) — — — ($5.1m) ($5.2m) ($1.3m) ($586k) — ($1.4m) ($13.0m)
Interest Income (Expense), Net — — — — — — — — $1.4m —

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.